» Articles » PMID: 34903123

Motivations for Prescription Drug Misuse Related to Mental Health Problems in Adults

Overview
Publisher Informa Healthcare
Date 2021 Dec 14
PMID 34903123
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Prescription drug misuse (PDM) is a significant public health problem associated with mental health symptoms.

Objectives: This project investigates the connections between PDM motivations and mental health to inform intervention efforts.

Methods: Using nationally representative adult data from the 2016-2018 National Survey on Drug Use and Health ( = 128,205; 53% female) this project investigated which motivations for misuse are related to past-year mental health problems including any mental illness, serious mental illness, major depressive episode, and suicidal thoughts. Complex samples logistic regression models of the main motivation of PDM for each mental health problem were conducted separately for each prescription drug class (i.e., opioids, tranquilizers, sedatives, and stimulants) while controlling for demographic characteristics.

Results: Adults that reported PDM were more likely than those with no PDM to endorse past year mental health problems. Compared to those that reported PDM of other medications, those misusing prescription opioids and tranquilizers to help with emotions and misusing sedatives to "relax or relieve tension" were more likely to have all categories of mental health problems. Those that misused prescription stimulants to "help study" had lower odds of all mental health problems.

Conclusions: While there were differences based on prescription drug class, a range of motivations increased adults' likelihood to have mental health problems and common themes were found across drug classes. While causality is still undetermined, prevention and intervention efforts that are multifaceted and individualized, while broadly providing adults with other ways to cope with negative emotions are likely to help reduce PDM.

Citing Articles

A prospective cohort of treatment-seeking patients with problematic use of prescription narcotic drugs: study protocol and baseline characteristics.

Burmester S, Kruger C, Hallgren J, Westman J, Franck J BMC Psychiatry. 2024; 24(1):937.

PMID: 39707239 PMC: 11661025. DOI: 10.1186/s12888-024-06368-w.

References
1.
Compton W, Volkow N . Abuse of prescription drugs and the risk of addiction. Drug Alcohol Depend. 2006; 83 Suppl 1:S4-7. DOI: 10.1016/j.drugalcdep.2005.10.020. View

2.
Compton W, Han B, Blanco C, Johnson K, Jones C . Prevalence and Correlates of Prescription Stimulant Use, Misuse, Use Disorders, and Motivations for Misuse Among Adults in the United States. Am J Psychiatry. 2018; 175(8):741-755. PMC: 6070393. DOI: 10.1176/appi.ajp.2018.17091048. View

3.
Grant B, Stinson F, Dawson D, Chou S, Dufour M, Compton W . Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiatry. 2004; 61(8):807-16. DOI: 10.1001/archpsyc.61.8.807. View

4.
Sullivan M . Depression Effects on Long-term Prescription Opioid Use, Abuse, and Addiction. Clin J Pain. 2018; 34(9):878-884. DOI: 10.1097/AJP.0000000000000603. View

5.
Kolodny A, Courtwright D, Hwang C, Kreiner P, Eadie J, Clark T . The prescription opioid and heroin crisis: a public health approach to an epidemic of addiction. Annu Rev Public Health. 2015; 36:559-74. DOI: 10.1146/annurev-publhealth-031914-122957. View